|Table of Contents|

Research Progress on the Pharmacological Effects of Evodiamine Compoundson Alzheimer’s Disease and Cerebrovascular Disease(PDF)

《南京师大学报（自然科学版）》[ISSN:1001-4616/CN:32-1239/N]

Issue:
2021年03期
Page:
137-141
Research Field:
·药学·
Publishing date:

Info

Title:
Research Progress on the Pharmacological Effects of Evodiamine Compoundson Alzheimer’s Disease and Cerebrovascular Disease
Author(s):
Kang Jingjing; Cui Ning
School of Medicine,Huanghe College of Science and Technology,Zhengzhou 450063,China
Keywords:
evodiamine; dehydroevodiamine; Alzheimer’s disease; cerebrovascular disease
PACS:
R285.5
DOI:
10.3969/j.issn.1001-4616.2021.03.020
Abstract:
Evodiamine and dehydroevodiamine are the essential components of chinese traditional medicine Euodia rutaecarpa. Studies have found that these two compounds can slow down the development of Alzheimer’s disease in multiple ways,in addition to the effect of evodiamine on cerebrovascular diseases. This article reviews the pharmacological effects of evodiamine compounds on Alzheimer’s disease and cerebrovascular disease in recent years,providing reference for clinical application of evodiamine and dehydroevodiamine in the treatment of Alzheimer’s disease and cerebrovascular disease.

References:

[1] BECKETT M W,ARDERN C I,ROTONDI M A. A meta-analysis of prospective studies on the role of physical activity and the prevention of Alzheimer’s disease in older adults[J]. BMC geriatrics,2015,15(1):109-116.
[2]王国佐,龚盛强,尹芳等. 脑血管疾病与阿尔茨海默病的联系及其机制[J]. 世界中医药,2016,11(9):1897-1900.
[3]JIAN L,YANG C,GANG R,et al. Screening hepatotoxic components in Euodia rutaecarpa by UHPLC-QTOF/MS based on the spectrum-toxicity relationship[J]. Molecules,2017,22(8):1264-1278.
[4]STRATMANN K,HEINSEN H,KORF H W,et al. Precortical phase of Alzheimer’s disease(AD)-related tau cytoskeletal pathology[J]. Brain pathology,2016,26(3):371-386.
[5]韩兆丰,刘士敏,刘晓倩,等. 吴茱萸碱对AD模型小鼠的保护作用及学习记忆能力的调节作用[J]. 现代中药研究与实践,2018,165(6):28-30.
[6]YUAN S M,GAO K,WANG D M,et al. Evodiamine improves congnitive abilities in SAMP8 and APPswe/PS1ΔE9 transgenic mouse models of Alzheimer’s disease[J]. Acta pharmacologica sinica,2011,32(3):295-302.
[7]王冬梅,马元武,袁树民,等. 柚皮苷及其与吴茱萸碱联合用药对APP～(swe)/PS～(ΔE9)转基因痴呆模型小鼠学习记忆能力的影响[J]. 中国实验动物学报,2012,20(2):59-63.
[8]WANG D,WANG C,LIU L,et al. Protective effects of evodiamine in experimental paradigm of Alzheimer’s disease[J]. Cognitive neurodynamics,2018,12(3):303-313.
[9]ZHANG Y F,WANG J Q,WANG C Y,et al. Pharmacological basis for the use of evodiamine in Alzheimer’s disease:antioxidation and antiapoptosis[J]. International journal of molecular sciences,2018,19(5):1527-1541.
[10]SHIN K Y,KIM K Y,SUH Y H. Dehydroevodiamine. HCl enhances cognitive function in memory-impaired rat models[J]. Korean journal of physiol pharmacol,2017,21(1):55-64.
[11]SHIN K Y,NOH S J,PARK C H,et al. Dehydroevodiamine. HCl protects against memory impairment and cerebral amyloid-β production in Tg2576 mice by acting as a β-secretase inhibitor[J]. CNS & neurological disorders drug targets,2016,15(8):935-944.
[12]LIU X,ZHOU J,ABID M D N,et al. Berberine attenuates axonal transport impairment and axonopathy induced by calyculin A in N2a cells[J]. Plos one,2016,11(3):e0152609.
[13]FANG J,LIU R,TIAN Q,et al. Dehydroevodiamine attenuates calyculin A-induced tau hyperphos-phorylation in rat brain slices[J]. Acta pharmacologica sinica,2010,28(11):1717-1723.
[14]PENG J H,ZHANG C E,WEI W,et al. Dehydroevodiamine attenuates tau hyperphosphorylation and spatial memory deficit induced by activation of glycogen synthase kinase-3 in rats[J]. Neuropharmacology,2007,52(7):1521-1527.
[15]孙文蕾. 吴茱萸碱对阿尔茨海默病模型大鼠HMGB1/TLR4/NF-κB信号通路的研究[D]. 石家庄:河北医科大学,2015.
[16]ZHAO T,ZHANG X,ZHAO Y,et al. Pretreatment by evodiamine is neuroprotective in cerebral ischemia:up-regulated pAkt,pGSK3β,down-regulated NF-κB expression,and ameliorated BBB permeability[J]. Neurochemical research,2014,39(8):1612-1620.
[17]LIU A J,WANG S H,HOU S Y,et al. Evodiamine induces transient receptor potential vanilloid-1-mediated protective autophagy in U87-MG astrocytes[J]. Evidence-based complementray and alternative medicine,2013(2):354840.
[18]任妮娜,杨奕樱,潘春等. 吴茱萸碱对动脉粥样硬化大鼠抗炎抗氧化作用的研究[J]. 贵阳中医学院学报,2018,40(2):21-26.
[19]WEI J,CHING L C,ZHAO J F,et al. Essential role of transient receptor potential vanilloid type 1 in evodiamine-mediated protection against atherosclerosis[J]. Acta physiologica,2013,207(2):299-307.
[20]SANTOS,CLáUDIA Y,SNYDER P J,et al. Pathophysiologic relationship between Alzheimer’s disease,cerebrovascular disease,and cardiovascular risk:a review and synthesis[J]. Alzheimer’s & dementia:diagnosis,assessment & disease monitoring,2017,7:69-87.

Memo

Memo:
-
Last Update: 2021-09-15